the innovation company

HEALTH

SPIDIMAN

Single Port Insulin Infusion for Improved Diabetes Management

Throughout Austria, 390,000 people have been diagnosed with type 1 or type 2 diabetes mellitus. Finding the proper balance between managing diabetes and living a normal daily life is usually quite complicated, especially for children and adolescents.

Within the framework of the EU project "SPIDIMAN", a new glucose sensor technology is being developed that allows more accurate measurements and better insulin delivery and, thus, improves the blood sugar control in patients.

JOANNEUM RESEARCH is coordinating this project, which includes eight Austrian and international partners. The project funding amounts to 6.4 million Euros and the proportion allotted to JOANNEUM RESEARCH is 1.5 million Euros.

Both project leaders are well-known experts in the field of diabetes research, and are respected within the scientific community. Univ. -Prof. Dr. Thomas Pieber acts as the medical director and Dr. Martin Hajnsek conducts the technical project management. The project consortium has defined special target groups, namely children and adolescents. "The new device, which combines improved sensor accuracy with a quicker response time, wider dynamic range and higher signal stability [than other models] has been especially designed to improve the daily lives of patients during childhood and adolescence," said Dr. Martin Hajnsek, who has worked intensively with sensors in medical applications for over 13 years. The ambitious project goal can only be achieved through the support and active cooperation of an international network of researchers with complementary fields of expertise. In the project network, SMEs, universities, hospitals and the Styrian research organization JOANNEUM RESEARCH work together.

 to SPIDIMAN homepage

Javascript ist nicht aktiviert - die Website kann an manchen Stellen nicht korrekt angezeigt werden.